Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.
about
Hypocalcemia in a Patient with Cancer.Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completionSevere Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review
P2860
Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Denosumab-associated hypocalca ...... n a tertiary hospital setting.
@en
type
label
Denosumab-associated hypocalca ...... n a tertiary hospital setting.
@en
prefLabel
Denosumab-associated hypocalca ...... n a tertiary hospital setting.
@en
P2093
P2860
P356
P1476
Denosumab-associated hypocalca ...... n a tertiary hospital setting.
@en
P2093
Andrew Liem Hieu Huynh
Douglas Forsyth Johnson
Scott Thomas Baker
P2860
P304
P356
10.1002/PDS.4045
P577
2016-06-03T00:00:00Z